Researchers using hematopoietic cell-specific GPR68 conditional knockout mice have shown that targeting GPR68 enhances the function of aging hematopoietic stem cells, providing a novel therapeutic strategy for age-related hematopoietic decline (He et al., 2025). The gene discussed is GPR68; the disease is age.